Trial Profile
Biomarker study of Itolizumab
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs Itolizumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 08 Nov 2016 New trial record